Aberle, J., Menzen, M., Schmid, S. M., Terkamp, C., Jaeckel, E., Rohwedder, K., . . . Birkenfeld, A. L. (2020). Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes. Nature Portfolio.
Chicago Style (17th ed.) CitationAberle, Jens, et al. Dapagliflozin Effects on Haematocrit, Red Blood Cell Count and Reticulocytes in Insulin-treated Patients with Type 2 Diabetes. Nature Portfolio, 2020.
MLA (8th ed.) CitationAberle, Jens, et al. Dapagliflozin Effects on Haematocrit, Red Blood Cell Count and Reticulocytes in Insulin-treated Patients with Type 2 Diabetes. Nature Portfolio, 2020.
Warning: These citations may not always be 100% accurate.